semaglutide and heart health cardiovascular outcomes align more closely with attained dose than achieved weight loss Semaglutide and the Heart: clinical

"I learned that it had a lot to do with me trying to eat my normal intake of food," shared one patient

Semaglutide is usually started at a lower dose to reduce side effects, then slowly increased

In the above-mentioned clinical trial, patients lost 6% of their starting body weight after 3 months or 12 weeks

The study also found that after semaglutide intervention, the food intake of obese mice decreased significantly, achieved by regulating appetite-related factors in the hypothalamus, indicating that semaglutide could penetrate the blood-brain barrier to reach the hypothalamus, brainstem, and arcuate nucleus through peripheral administration ( + neurons in the arcuate nucleus co-express GLP-1R and leptin receptors, and chemogenetic activation of POMC Glp1r+ neurons leads to reduced food intake in male mice ( In addition to regulating appetite, the semaglutide also affects insulin secretion, blood glucose homeostasis, energy expenditure, and lipid metabolism processes, as well as serum metabolism